Kumaraguru Raja
Stock Analyst at Brookline Capital
(1.89)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
INTS Intensity Therapeuti... | Upgrades: Buy | 3 | n/a | n/a | 1 | Aug 12, 2025 | |
PALI Palisade Bio | Maintains: Buy | 16 16 | 0.75 | 2033.33% | 2 | May 13, 2025 | |
QNCX Quince Therapeutics | Initiates Coverage On: Buy | 9 | 1.63 | 452.15% | 1 | Dec 18, 2024 | |
SABS SAB Biotherapeutics | Initiates Coverage On: Buy | 8 | 2.18 | 266.97% | 1 | Jun 7, 2024 | |
FBRX Forte Biosciences | Initiates Coverage On: Buy | 100 | 11.43 | 774.89% | 2 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 150 | n/a | n/a | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 15 | 3.51 | 327.35% | 1 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 9 | 1.9 | 373.68% | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 21 | 3.23 | 550.15% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 15 | n/a | n/a | 1 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 90 | 32.06 | 180.72% | 1 | Dec 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 290 310 | 3.6 | 8511.11% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 33600 | 5.34 | 629113.48% | 1 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 320 | 0.53 | 60277.36% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 120 | n/a | n/a | 1 | Mar 25, 2021 |